FDA Center for Veterinary Medicine Issues Warning Letter to Elanco Animal Health USA
February 19, 2026
February 19, 2026
WASHINGTON, Feb. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Elanco Animal Health USA from the Center for Veterinary Medicine:
* * *
Recipient: Jeffrey Simmons, President and CEO, Elanco Animal Health USA, 2500 Innovation Way, Greenfield, IN 46140, United States
Issuing Office: Center for Veterinary Medicine, United States
Re: NADA 141-550 Pradalex(TM) (pradofloxacin . . .
* * *
Recipient: Jeffrey Simmons, President and CEO, Elanco Animal Health USA, 2500 Innovation Way, Greenfield, IN 46140, United States
Issuing Office: Center for Veterinary Medicine, United States
Re: NADA 141-550 Pradalex(TM) (pradofloxacin . . .